期刊文献+

视网膜中央静脉阻塞治疗研究进展 被引量:2

Study progression in the treatment of central retinal vein occlusion
下载PDF
导出
摘要 视网膜中央静脉阻塞是临床上常见的视网膜疾病,因严重的并发症导致视力下降甚至失明,到目前为止尚无针对其病因的确切有效的治疗方法。近年来激光光凝、激光诱导视网膜脉络膜吻合、视网膜静脉t-PA注射、玻璃体腔内注射、放射状切开等手术方法为视网膜中央静脉阻塞带来了新的观念,我们将对上述几种方法的实验和临床研究作简要综述。 Central retinal vein occlusion(CRVO) is a common retinal disease which may cause unilateral loss of vision and even blindness because of serious complications.There is presently no effective treatment which directly aims at its etiology.In recent years,laser plotocoagula-tion,laser-induced chorioretinal venous anastomosis,retinal vein t-PA injection,intravitreal injection and radial optic neurotomy have brought new concepts for CRVO.This article will make a brief overview of the above-mentioned methods.
作者 何琼 游志鹏
出处 《国际眼科杂志》 CAS 2009年第9期1744-1746,共3页 International Eye Science
关键词 视网膜中央静脉阻塞 治疗 进展 central retinal vein occlusion thera-py progression
  • 相关文献

参考文献19

  • 1Krill AE,Archer D,Newell FW.Photocoagulation in complications secondary to branch vein occlusion.Arch Ophthalmol 1971 ;85(1):48-60.
  • 2张惠蓉.视网膜病临床和基础研究.太原:山西科学技术出版社 1999:5.
  • 3卢宁,李志辉.视网膜静脉阻塞治疗新方法的实验和临床研究[J].国外医学(眼科学分册),2001,25(2):103-106. 被引量:10
  • 4Weiss JN.Treatment of central vein occlusion by injection of tissue plasminogen activator into a retinal vein.Am J Ophthalmol 1998;126(1):142-144.
  • 5Mcallister IL,Constable U.Laser induced chorioretina venous anastomosis for treatment of nonischemic central retinal vein occlusion.Arch Ophthalmol1995;113(4):456-462.
  • 6Mcallister IL,Douglas JP,Constable IJ,et al.Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion:evaluation of the complications and their risk factor.Am J Ophthalmol 1998;126(6):219-229.
  • 7Leonard BC,Coupland SG,Kertes PJ,et al.Long-term follow-up of a modified technique for laser-induced chorioretinal venous anastomosis in nonischemic central retinal vein occlusion.Ophthalmology 2003;110(5):948-955.
  • 8Lu N,Wang NL,Li ZH,et al.Laser-induced chorioretinal venous anastomosis using combined lasers with different wavelengths.Eye 2007;21(7):962-967.
  • 9Antcliff RG,Spalton DJ,Stanford MR,et al.Intravitreal triamcinolone for uveitic cystoid macular edema:an optical coherence tomography study.Ophthalmology2001;108(4):765-772.
  • 10Penfold PL,Wen L,Madigan MC,et al.Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1(ICAM-1) expression of the ECV304 cell line:implications for macular degeneration.Clin Exp Immunol 2000;121(3):458-465.

二级参考文献20

共引文献18

同被引文献36

  • 1张海涛,李学晶,刘超.视网膜中央静脉阻塞治疗新进展[J].中国中医眼科杂志,2010,20(5):300-303. 被引量:8
  • 2熊毅彤,叶纹,孙莉.倍频固体激光治疗视网膜静脉阻塞疗效分析[J].中国实用眼科杂志,2007,25(2):158-160. 被引量:12
  • 3Noma H, Funatsu H, Harino S, et al. Pathogenesis of macular e- dema associated with branch retinal vein occlusion and strategy for treatment. Nihon Ganka Gakkai Zasshi, 2010, 114: 577-591.
  • 4Fortunato P, Pollazzi L, Baroni M, et al. Venous retinal flow reperfusion mechanisms following radial optic neurotomy with ad- junctive intraocular triamcinolone in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol, 2010, 248: 167-173.
  • 5Babarivand N, Hariri A, Javadzadeh A, et al. Pars plana vitrec- tomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusion. Clin Ophthalmol, 2011, 5: 1089-1093.
  • 6Raszewska-Steglinska M, Gozdek P, Cisieeki S, et al. Pars pla- na vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol, 2009, 19 : 1055- 1062.
  • 7Liang XL, Chen HY, Huang YS, et al. Pars plana vitrectomy and internal limiting membrane peeling for macular ocdema sec- ondary to retinal vein occlusion: a pilot study. Ann Acad Med Singapore, 2007, 147 : 293-297.
  • 8DeCroos FC, Shuler Jr RK, Stinnett S, et al. Pars plana Vitrec- tomy, internal limiting membrane peeling, and panretinal en- dophotocoagulation for macular edema secondary to central retinal vein occlusion. Am J Ophthalmol, 2009, 4: 627-633.
  • 9Kadam RS, Tyagi P, Edelhauser HF, et al. Influence of choroi- dal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide. Int J Pharm, 2012, 434: 140-147.
  • 10Bombaek AS, Canetta PA, Beck LH Jr. , et al. Treatment of re- sistant glomernlar diseases with adrenocorticotropic hormone gel: a prospective trial. Am J Nephrol, 2012, 36: 58-67.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部